Treating depression during COVID-19: Considerations for psychological and psychiatric treatment
Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD
View slides from this presentation
Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.
Related resources
People who catastrophize often hold beliefs that danger is always present…
“Moral injury is when you do something, witness something, or learn about…
People with borderline personality disorder (BPD) experience difficulty in…